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Abstract
Background: This study aimed to describe parental perceptions of the causes of autism spectrum 
disorder (ASD) in an ethnically diverse sample and explore whether these perceptions relate to 
treatment choices.
Methods: The sample consisted of White (n=224), Hispanic (n=85) and Asian (n=21) mothers of 
a child with ASD. A mixed methods approach was used in this secondary analysis focusing on 
parental perceptions about the causes of ASD and the relationship of these to utilization of 
services and treatment.
Results: Environmental and genetic factors were most often believed to be the cause or one of 
the causes of ASD by mothers across all ethnic groups studied. Asian mothers were more likely to 
cite multiple causes. Environmental causes were associated with receiving 20 or more hours of 
autism related services per week; while belief in environmental exposures and vaccines and 
medications as causes were associated with complementary-alternative medicine (CAM) use.
Conclusion: Our findings suggest that ethnic differences in autism causal beliefs and treatment 
choices may exist. Future research should be conducted to specifically confirm the findings, to 
understand parental motivation behind their service and treatment choices; and to gain more 
insight into the types, usage and sources of CAM treatments. Clinicians can use parental autism 
causal beliefs in discussions about treatment recommendations.
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Introduction
It is estimated that autism spectrum disorder (ASD) affects 1 in 59 US children (Baio, et al. 
2018). For researchers and clinicians, understanding family perspectives in ASD care is 
integral to research in health system design and forming therapeutic clinical relationships 
(Carbone, et al. 2013). Research on family perspectives in ASD has focused on families’ 
perceptions of the possible causes of ASD. The body of this research reveals that parents’ 
perceptions of causes have evolved (Elder, 1994; Harrington, Patrick, Edwards, & Brand, 
2006; Harrington, Rosen, Garnecho, & Patrick, 2006; Russell, Kelly, & Golding, 2009; Al 
Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010; Goin-Kochel, Mire, & Dempsey, 
2015; Zuckerman, Lindly, & Sinche, 2016; Fischbach, Harris, Ballan, Fischbach, & Link, 
2016) as the scientific community’s hypotheses about the pathophysiologic mechanisms 
underpinning ASD have changed in the last fifty years. The growing consensus in both 
communities is that ASD is a multi-factorial neurodevelopmental disorder involving the 
interaction of environmental and genetic factors. However, there is less investigation into the 
other aspect of family perspectives in ASD care, namely, what influences the use of services 
and treatments by parents of children with ASD.
There are many potential drivers of ASD service use. In investigating ASD service use from 
a family perspective, it is helpful to consider parents’ decision-making and choices around 
utilization of services and treatment for their child with ASD as a ‘health behavior’. There 
are accepted theories of health behavior and behavior change, such as the Health Belief 
Model (Janz & Becker MH, 1984) and the Theory of Planned Behavior (Ajzen & Fishbein, 
1980), which define and categorize which factors could lead to service use. From that point 
of departure, previous research in ASD care helps to refine which specific possible factors 
highlighted in health behavior models are most promising to consider further. Such research 
suggests that parents’ beliefs, attitudes and subjective norms around ASD care can play 
mediating roles, and health behaviors can be changed by targeting these constructs. In a 
review, Hebert and Koulouglioti (2010), cited 13 articles published from 1995 through 2009 
and concluded that there is limited research directly examining the link between parental 
beliefs and their decision regarding interventions for their child with ASD. That same year, 
Al Anbar et al. (2010) studied this link and found causal beliefs to have strong effects on 
treatment use. Both external and hereditary causal attributions were associated with the use 
of nutritional treatments, especially special diets and vitamin supplements. In a review, 
Carlon, Carter, & Stephenson (2013) found that there are a large number of factors likely to 
be involved in parents’ decision-making around utilization of treatments and services. As 
such, they recommended that future research should focus on understanding parents’ relative 
weighing of these factors when making decisions. Their review focused only on declared 
decision-making factors, acknowledging that implicit underlying factors such as causal 
beliefs may also weigh in the decision-making process. Indeed, Zuckerman, Lindly, & 
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Sinche (2016) called for examining the impact of beliefs about causes of ASD on treatment 
utilization.
In addition beliefs, norms, and attitudes, previous research also suggests focusing on 
families’ own characteristics, such as primary language, socio-economic status (SES), 
ethnicity or race (Hebert & Koulouglioti, 2010), as other possible determinants of ASD care. 
In a review, Mandell and Novak (2005) reported some limited evidence to suggest members 
of different cultures respond differently to similar impairments of ASD, including 
interpretation of symptoms, family decisions regarding interventions and interactions 
between families and the healthcare system. In 2010, Al Anbar et al. found parental age and 
years of education were not associated with any treatment (Al Anbar 2010). Conversely, a 
recent study found that some social determinants of health (SDH) were associated with 
variation in health services utilization (Zuckerman, Lindly, Sinche, & Nicolaidis, 2015). 
Near-poor families were less likely to believe they had the power to change their child’s 
condition; parents of minority children were more likely to believe their child’s condition 
was temporary than white parents; and less educated parents or those from lower SES were 
more likely to think their child’s ASD was a mystery. Ultimately, the authors noted that it is 
unclear whether differing beliefs are helpful or harmful or what the variation in parental 
beliefs even means.
Our overall goal for this current exploratory and descriptive study is to build on these health 
behavior theories refined by this previous research to inform future research directions and 
clinician-family communications about ASD treatment choices (Zuckerman et al., 2016). We 
used a stepwise mixed methods secondary analysis of a large dataset to expand on current 
literature about parents’ perception of ASD causes, how these may influence treatment 
choices, and how these may be influenced by parental demographic characteristics. We 
pursued three specific analytic steps. First, we sought to qualitatively analyze mothers’ 
beliefs about ASD causes and reported ASD treatment utilization. Second, we sought to 
describe the distribution of ASD causal beliefs and treatment utilization overall and by race/
ethnicity and primary language. Lastly, we sought to investigate whether ASD causal beliefs 
were associated with ASD treatment utilization.
Methods
Participants
The (REMOVED FOR BLINDING) study is an ongoing (starting in January 2003) 
population-based case-control study with subjects sampled from three strata: children with 
autism spectrum disorder (ASD), children with developmental delay (DD) but not ASD, and 
children selected from the general population (GP). We limited this secondary analysis to 
families of children diagnosed with ASD to focus on the parental perceptions about the 
causes of ASD and the relationship of these to utilization of services and treatment. A total 
of 330 mothers with children with ASD and who met our criteria for this secondary analysis 
were enrolled in the primary study between January 2003 and December 2009, the 
timeframe for our secondary analysis. All participating children met the following eligibility 
criteria: (a) between the ages of 24 and 60 months, (b) living with at least one biologic 
parent who speaks English or Spanish, (d) born in California, and (e) residing in one of the 
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catchment areas of a specified list of Regional Centers (RC) in California. Children with 
ASD are identified from within the California Department of Developmental Services 
(DDS), which provides services for individuals who qualify with developmental disabilities, 
regardless of race, ethnicity, socioeconomics, or immigration status.
The diagnosis of ASD was confirmed with the Autism Diagnostic Interview, Revised (ADI-
R) (Le Couteur, Lord, & Rutter, 1993) and Autism Diagnostic Observation Schedule 
(ADOS) (Lord et al., 2000) administered by trained, research-reliable clinicians. We focused 
on the causal beliefs of mothers because they were nearly always the parent who completed 
the research interview and questionnaires. We included data only from mothers who self-
identified as White, Hispanic, and Asian race/ethnic groups because the proportions of 
mothers from other ethnic groups were too small to be generalizable. Mothers who reported: 
White race only and no other race or ethnicity were coded as “White” (n=224); Hispanic 
ethnicity regardless of the race reported were coded as “Hispanic” (n=85); and Asian race 
only and no other race or ethnicity were coded as “Asian” (n=21). The institutional review 
boards for the State of California and the BLINDED approved the study. Informed consent 
was obtained from all participants prior to data collection.
Data Collection
Every child with ASD in the BLINDED study received a set of standardized measures 
described previously (citation removed for blinding). Measures relevant to this secondary 
analysis include the Multiple Language Questionnaire (MLQ); the Environmental Exposure 
Questionnaire (EEQ); and the physician-administered child and family medical history 
interview, including a Services and Treatment Interview (STI).
The MLQ is a brief questionnaire used to determine languages used at home. Primary 
language was determined based on the MLQ question “What is the language spoken most 
often to your child?” The EEQ is a structured telephone interview with the mother and 
includes questions about demographic characteristics, environmental exposures and the 
open-ended question, “What do you think causes Autism?” The STI provided data on 
treatments sought in four areas. Area 1 encompassed ASD-related services provided by 
professionals. These included: behavioral modification therapy through a psychologist or 
paraprofessional/home trainer; speech therapy; occupational therapy; physical therapy; 
sensory integration therapy; psychiatry; vision services; nutrition; music therapy; and art 
therapy. This outcome variable was categorized as yes/no for receiving any “professional” 
services. Area 2 included the total number of service hours per week the child is currently 
receiving. This outcome variable was categorized as ≥ 20 hours per week or ≤ 20 hours per 
week. While there is a limited but growing evidence-base to support any dose or mode of 
therapy for ASD in terms of long-term outcomes, some experts recommend 20 hours per 
week or more of autism specific services in early childhood based on promising results in 
clinical trials (National Research Council, 2001). Area 3 encompassed all conventional 
prescription medications used by the child. These included psychotropic medications; anti-
convulsants; gastric reflux medications; constipation medication; other miscellaneous 
medications; and medically prescribed diets. Area 4 related to ASD treatment currently or 
ever received by the child through complementary and alternative medicine therapies, 
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special diets, vitamins, food supplements, or alternative treatments including special 
injections (e.g., immunoglobulins, secretin, chelation agents). These definitions have been 
fully described previously (Citation removed for blinding).
Qualitative Analysis
Two researchers with different areas of expertise independently coded parent responses to 
the open-ended question “What do you think causes autism?” Specific coding categories 
were created using a hybrid deductive and inductive process. First, we predetermined 
categories based on literature which included: environmental, genetic, vaccines, maternal 
factors, childhood illnesses, antibiotics, food, mercury, autoimmune/immune-related, 
pregnancy complications, old age when conceiving, maternal drugs/alcohol use, neonatal/
childhood illness and neurological. Then, additional categories were created based on 
emerging themes from parent responses. In the interim, the two researchers kept notes and 
had regular discussions and check-ins about how to code parent responses. Causal beliefs 
were then collapsed into six main themes: Environmental, Genetic, Vaccines/Medications, 
Biomedical/Maternal, Biomedical/Child, and “Don’t Know.” This last category consisted of 
only those mothers who stated they did not know what causes autism and did not make any 
guesses. After independent coding, the percent agreement for responses was quantified and 
discrepancies >1% were identified, discussed and resolved. For example, if one researcher 
coded 2.4% of all responses into the ‘immune’ category and the second researcher coded 
3.5% of all responses into the ‘immune’ category, then the two researchers discussed the 
types of responses coded into that category until there was consensus about how to handle 
such discrepancies. Only two categories (prior to grouping into the six main categories) had 
discrepancies >1%.
Statistical Analysis
Descriptive Analyses—We examined demographic characteristics across race/ethnic 
groups using likelihood ratio chi-square tests for categorical variables (or Fisher’s exact test 
when cell sizes were <5) and one-way analysis of variance (ANOVA) for continuous 
variables. We calculated proportions to describe the distribution of the categories of causes 
of ASD overall and by race/ethnicity. In the course of our qualitative analysis, we discovered 
that mothers could report more than one causal belief. Therefore, we calculated proportions 
to describe the distribution of the number of ASD causal beliefs held by participants, overall 
and by race/ethnicity.
Comparative Analyses—We used regression analyses to test for apparent differences 
while adjusting for maternal demographic characteristics. Because participants often cited 
more than one cause and beliefs are not strongly correlated with each other (Zuckerman et 
al., 2016), we examined differences in each categorical theme of perceived ASD cause 
between race/ethnicity groups (Hispanic and Asian each vs. White respondents). Second, we 
examined differences in each perceived ASD cause category by language (English-speaking 
vs. non-English-speaking) irrespective of race/ethnicity (Hispanic or Asian). Third, we 
investigated the differences in number of causes cited by parents by race/ethnicity (Hispanic 
and Asian each vs. White respondents). Fourth, we examined differences in services and 
treatment utilization between race/ethnic groups (Hispanic and Asian each vs. White 
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respondents). Fifth, we examined the relationship between ASD causal beliefs and service 
and treatment utilization. For binary outcomes, we estimated prevalence ratios and 95% 
confidence intervals using Poisson regression with robust error variance. For the outcome 
number of causes, we used a Poisson regression model to estimate the mean difference in 
log counts (β coefficient) and 95% confidence intervals. In all models we adjusted for 
(where appropriate) maternal education, race/ethnicity and/or primary language.
Results
Descriptive Outcomes
In our study sample, over half of Asian and White mothers had completed formal higher 
education (college degree or higher) compared to one-third of Hispanic mothers, p<0.0001 
(Table 1). Approximately two-thirds of this study population was White, one-quarter was 
Hispanic and less than ten percent was Asian. Approximately a quarter of Asian mothers and 
one-third of Hispanic mothers reported a language other than English as their primary 
language. Table 2 provides a list of the specific ASD causes that resulted from our 
qualitative analysis, organized within the six categorical themes into which they were 
grouped for quantitative analyses: Environmental, Genetics, Vaccines/Medications, 
Biomedical/Maternal, Biomedical/Child, and Don’t Know. Table 3 provides the distribution 
of categories of ASD causes in the sample regardless of the number of causes reported by a 
given participant. That is, respondents can be counted more than once if they gave more than 
one cause. Overall, Genetic (51.5%) and Environmental (50.9%) factors were the most 
commonly cited causes of ASD, with Biomedical/Maternal being the least (5.5%). Table 4 
presents the distribution of the number of causal belief categories reported by each mother. 
Overall, mothers were as likely to report singular (1 cause or don’t know; 48.5%) than 
multiple (2 or more causes; 51.5%) causal beliefs. Of mothers who cited causes of ASD, 
most cited two causes, with few citing 3 or 4 causes and the largest number of causes being 
5 (reported by only 1 participant).
Comparative Outcomes
Table 3 summarizes the findings of comparison in causal belief categories with respect to 
race/ethnicity. There was a difference in percent, with Hispanic mothers being less likely 
(41.2%) and Asian mothers being more likely (61.9%) to cite genetic causes than White 
mothers (54.5%), but when adjusted for maternal education and language, there were no 
statistically significant differences. Similarly, comparison of causal beliefs between mothers 
whose primary language was English versus non-English yielded no statistically significant 
differences (data not shown). Table 4 contains results of comparisons in the number of 
causals belief categories reported by each mother by race/ethnicity. Percents differed by 
race/ethnicity, with Asian mothers appearing more likely to report more than one cause (the 
one person reporting 5 causes was an Asian respondent). This was reproduced in crude 
Poisson models, where Asian mothers cited 1.25 more causes than White mothers (95% CI 
1.01, 1.54; p = 0.036), but was not statistically significant when adjusted for maternal 
education and language (1.22; 95% CI 1.0002, 1.50; p = 0.0498). The comparison for 
Hispanic respondents to White respondents was not significant. There was great variability 
in the specific combinations and types of causes when mothers reported more than one 
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cause, precluding further analysis of these combinations by race/ethnicity and supporting 
other evidence that specific causes are not correlated with each other. Ethnic/Race 
comparisons of services and treatment utilization did not reveal any significant differences 
between groups when stratified by education level (data not shown).
Several noteworthy relationships emerged between causal beliefs and utilization of services 
and/or treatments after adjusting for maternal education, maternal race/ethnicity and 
maternal primary language (Table 5). The children of mothers who reported Environmental 
factors as a cause of ASD were more likely to receive 20 or more hours of services per week 
and to use complementary-alternative medicine (CAM) treatments than those who did not 
cite Environmental causes (adjusted PR [aPR] 1.38, 95%CI 1.09, 1.78 and aPR 1.72, 95%CI 
1.16, 2.56, respectively). Similarly, those who cited Vaccines/Medications as a cause were 
more likely to report use of CAM treatments than those who did not cite Vaccines/
Medications as a cause (aPR 1.65, 95%CI 1.13, 2.42). Finally, mothers who reported “Don’t 
Know” as a cause were more likely to use conventional medications than mothers who cited 
at least one causal factor (aPR 1.55, 95% CI 1.02, 2.36).
Discussion
Our overall goal was to explore family perceptions of ASD care in an effort to provide new 
insight on factors that may influence ASD service use. We specifically examined ASD 
causal beliefs and family demographic factors as potential levers of ASD treatment choice 
based on health behavior theories; a novel and recommended approach (Carlon, Carter, & 
Stephenson, 2013) refined by previous research. Beginning with our investigation of causal 
beliefs, we found that maternal beliefs about the causes of ASD did not differ across ethnic 
groups nor by language fluency. In general, environmental and genetic factors were most 
often believed to be the cause or one of the causes of ASD by mothers across all ethnic 
groups. The least endorsed causes were maternally-related biomedical factors. As multi-
factorial causes are being increasingly supported by research, the public acceptance of such 
findings has grown as well. At least half of our sample believes environmental or genetic 
factors are implicated in the development of ASD. These findings are consistent with the 
literature describing trends in public beliefs about ASD causes over time, showing that 
beliefs in environmental and genetic factors have increased while beliefs that vaccinations 
cause ASD have decreased (Harrington, et al., 2006; Harrington, et al., 2006; Russell et al., 
2009; Al Anbar et al., 2010; Goin-Kochel et al., 2015; Fischbach, et al. 2016; Zuckerman et 
al. 2016; Mitchell & Locke, 2015).
The decline in vaccines being cited as a cause of ASD coincides with the retraction of the 
Wakefield study that suggested a possible link between the measles-mumps-rubella (MMR) 
vaccine and ASD (Wakefield et al., 1998) and with the increase of epidemiological studies 
that have weighed against this hypothesis, to a point where it can reasonably be considered 
disproven (Institute of Medicine, 2012; Taylor et al., 1999). It is worth noting that studies 
continue to indicate prevailing beliefs that vaccinations cause ASD may still exist among 
various groups, including parents of children with ASD (Bazzano, Zeldin, Schuster, Barrett 
& Lehrer, 2012; Wolff & Madlon-Kay, 2014; Fischbah et al., 2016; Mitchell et al., 2015). It 
is unclear why vaccine-associated beliefs persist in studies, although it may depend in part 
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on the group sampled (scientists, childcare providers, general public, or parents) (Fischbah 
et al., 2016; Mitchell et al., 2015). One study found that parents tend to incorporate new 
information within their existing beliefs about the etiology of ASD (Reiff et al., 2017). 
Perhaps for individuals who have experience with adverse vaccine reactions, the plausibility 
that vaccines cause ASD would fit into their existing beliefs where vaccinations are 
associated with adverse effects.
It was not our intent to investigate the number of causal beliefs reported by each mother. 
However, we did proceed with the analysis, as it became apparent that mothers reported 
more than one causal belief category as often as reporting a single one. Reporting more than 
one causal belief is consistent with previous studies (Harrington et al., 2006; Harrington et 
al., 2006; Al Anbar et al., 2010; Zuckerman, et al., 2016; Reiff et al., 2017). However, 
previous studies have not described to the extent that we have, the types, number and 
combination of causes cited by parents. In doing so, we found that parents typically cited 
between one and five causes of autism, where the greatest number of mutually exclusive 
combinations involved parents who cited two causes. Overall, there was great variability in 
the specific combinations and types of causes when more than one cause was cited. The 
number of mutually exclusive combinations is actually greater than what was depicted in our 
summary table, since parents actual responses were coded and collapsed into categorical 
themes. Indeed, in one qualitative study, over 40 different environmental causes were 
identified regarding the etiology of ASD, illustrating the array of beliefs as well as the 
potential degree of conviction that some beliefs carry over others (Russell et al., 2009), all of 
which add complexity to understanding how beliefs might influence health seeking 
behaviors. Consistent with Zuckerman et al. (2016) there did not appear to be any 
correlation between the specific types of causal belief categories when multiple were 
reported, supporting our analytic approach in comparisons by race/ethnicity and language. 
When looking at race/ethnicity, Asian mothers were more likely to cite more than one cause 
compared to White mothers. This finding should be interpreted with caution, as it was 
marginally significant after adjusting for maternal education and language.
We did not find differences in service utilization and treatment across ethnic groups. This 
may be due to identifying participants from the California Department of Developmental 
Services (DDS) database, where the local Regional Center determines eligibility and 
coordinates provision of services for California children with ASD. Perhaps there is little 
variation in service utilization between ethnic groups because there are specific Regional 
Center referral guidelines based on the Lanterman Developmental Disabilities Act 
(www.dds.ca.gov) for determining eligibility and provision of services. Previous studies 
have shown though, even within this highly coordinated statewide agency responsible for 
identifying and providing services for children and adults with developmental disabilities, 
disparities still exist with all racial and minority groups having significantly lower odds of 
receiving any Regional Center services and of those who received services, lower 
expenditures spent compared to whites (Harrington & Kang, 2008).
When looking at treatments not dictated by the Regional Center, namely CAM, differences 
across ethnic groups were not found. CAM use was relatively consistent across all ethnic 
groups (27.9% White, 20.3% Hispanic, 19.2% Asian; p=0.35). This finding differs from 
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previous findings that Latino children recently diagnosed with ASD were six times more 
likely than children of other ethnicities to use non-traditional treatment strategies (Levy, 
Mandell, Merhar, Ittenbach, & Pinto-Martin, 2003). These differing results may be due in 
part to variation in national origin among Hispanics and/or education level. Our Hispanic 
sample in California is largely of Mexican origin with a higher education level than that 
typically seen in most research studies, such as the Hispanic sample from Philadelphia, 
Pennsylvania (Levy et al., 2003). Our findings about CAM use overall is consistent with a 
more recent multi-site, population-based study showing that 28% of the sample reported any 
CAM use (Perrin et al., 2012). This is in contrast to other studies reporting much higher 
prevalence of CAM use overall, ranging from 50–95% (Akins, Angkustsiri, & Hansen, 
2010; Levy & Hyman, 2008). In summary, our study adds to the variability of findings in 
ASD-associated CAM.
As in previous research, we found relationships between particular causal beliefs and 
utilization of services and treatment (Dardennes, Al Anbar, Prado-Netto, Kaye, & 
Contejean, 2011; Zuckerman et al., 2015). First, mothers who “Don’t Know” what causes 
ASD were more likely to use conventional medications compared to mothers who cited 
specific cause(s). One explanation might be that mothers who know what causes their 
child’s ASD may look for specific types of treatments for the given cause, even if non-
conventional, while those who don’t know are likely to take recommended ones. That is, 
parents who “don’t know” may rely more heavily on their child’s healthcare provider’s 
guidance, where use of conventional medications is common. Second, belief in 
Environmental causes was associated with receiving 20 or more hours of educational/
behavioral autism-related services per week. Conceivably parents who believe in an 
environmental cause (e.g., mercury in fish, pesticides, air pollution) may view their child’s 
ASD as more malleable or likely to improve with interventions. Such parents may be more 
willing to try a wider range of interventions. Another possibility is that mothers who believe 
in an environmental cause of ASD may prefer to try “natural” remedies often associated 
with CAM (Astin, 1998). We did not investigate whether the number of causal beliefs held 
by each mother predicted service utilization or treatment use. First, this was an unanticipated 
finding and thus, precluded preplanned analysis. Second, there is no apparent correlation 
between specific causal beliefs reported among those holding multiple, and to group those 
holding multiple beliefs together just on the nature of the number of beliefs reported may be 
a false presumption. The finding does, however, highlight a need for such a preplanned 
analysis in future studies.
Third, we found that belief in Environmental causes and Vaccines/Medication causes were 
also associated with CAM use. Those who believe vaccines and conventional medications 
cause ASD may distrust conventional medicine and utilize CAM exclusively instead. 
Hanson et al. (2007) found the main reason for choosing CAM over conventional treatments 
among families with ASD was concern about the safety and side effects of prescribed 
medications. Another study demonstrated the potential role of anti-vaccine conspiracy 
beliefs in shaping health-related behaviors (vaccination intention), where mediating 
variables include perceived dangers of vaccines, feelings of powerlessness and mistrust in 
authorities (Jolley & Douglas, 2014). Conversely, Wei et al. (2009) found that vaccine 
refusers do not generally opt out of the healthcare and continue to use services, although 
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with lower utilization for some services in children age 2 and under. Of greater concern, is 
literature suggesting that correcting misinformation may actually be problematic. In a 
randomized trial where parents were assigned to pro-vaccine messaging interventions, none 
of the interventions increased intent to vaccinate a future child. Moreover, the intervention 
that corrected false claims about the vaccine/autism link actually decreased intent to 
vaccinate in parents with the least favorable attitudes (Nyhan, Refler, Richley, & Freed, 
2014). Another study tested a new set of strategies to correct vaccine misinformation, but 
concluded such strategies are ineffective and often backfire, reinforcing misconceptions 
about vaccination and reducing intentions to vaccinate (Pluviano, Wat & Sala, 2017). The 
latter study discussed literature examining the consequences of misinformation and the 
cognitive processes involved that complicate reversal or undoing misconceptions. This 
observation leads us back to the “Individual level” as a theoretical and practical focal point 
for researchers and practitioners to engage. Healthcare providers need to encourage and 
facilitate open discussions with families about current knowledge regarding etiologies, the 
relationship (or lack thereof) of etiologies to evidence based treatments, and the importance 
of ongoing communication regarding decisions about CAM treatment choices that require 
monitoring for safety and efficacy.
Findings from this case-control study suggest beliefs about the etiology of ASD may 
influence the types, consistency and intensity of services and treatments sought. Reiff et al. 
(2017) qualitatively explored parental beliefs and how they affect expectations and pursuit of 
treatment. Parents who received pathogenic genetic testing results thought of their child’s 
condition as more permanent and less modifiable, which, for some parents, resulted in 
decreased expectations and less motivation to pursue treatment. More importantly, the study 
highlights that healthcare providers should be aware of the ways in which genetic 
information can influence attitudes and decisions about treatment, and actively discuss 
attitudes with families. Our findings support the need for clinicians, health professionals and 
service providers to share current knowledge about the complex etiology of ASD and inquire 
about parents’ own beliefs that may influence their use of both evidence-based and CAM 
treatments.
Our results should be taken in the context of some limitations. First, there was a possible 
confounding effect of the study name (BLIND), which implicates genetics and environment 
as having potential roles in the development of ASD. Similarly, administration of the 
Environmental Exposure Questionnaire (EEQ) may have primed participants to consider 
possible environmental causes for ASD. However, the study was commonly referred to as 
“the (BLIND) study”, rather than its entire name, which may have negated some of the 
name’s influence. Second, we had a limited sample of ethnic minority groups to make 
broader comparisons and as such, the generalizability of our findings to more diverse 
populations is limited. However, it is generally difficult to obtain data from families with 
autism spectrum disorder outside of large prospective studies such as this one and this is 
especially true for diverse populations. In that light, the diversity we have is a strength. 
Third, our data is older although it takes time for public uptake (Institute of Medicine, 2001), 
and as our cited literature points out, not much has changed in that time. Finally, more 
detailed information regarding the intensity and duration of past and present use of services 
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and treatments, particularly CAM treatments, would have allowed for a more in-depth 
exploration between parental perceptions of ASD causes and treatments of choice.
As an exploratory and descriptive study guided by previous research and health behavior 
theory, our findings help inform researchers that there may be ethnic differences, which exist 
and argue for a larger, specific study to quantify them. More importantly, future research 
should seek to understand parental motivation behind their choices of services and 
treatments beyond those currently considered evidence based and conventional 
interventions. Future research should also attempt to gain more insight into the types, usage 
and sources of CAM treatments. Most families adopt multiple treatment approaches and 
many discontinue treatment if there is no perceived improvement (Bowker, D’Angelo, 
Hicks, & Wells, 2011). However, much remains to be determined in terms of understanding 
why families receive certain treatments, outside of the individual/personal factors we chose 
to focus on in this study. For example, both age and severity of diagnosis seem to play a role 
(Mire, Raff, Brewton, & Goin-Kochel et al., 2015; Bowker et al., 2011). Mire, et al. (2015) 
found the preschool years to be when most treatment types were being used, however 
psychotropic medication use increased as children increased in age. CAM treatment use 
remained steady across age groups. Future studies should examine how causal beliefs, 
among other factors, might influence treatment choices across the lifespan of an individual 
with ASD. Specifically, families’ choices and use of services can be related to healthcare 
access and quality that may require more comprehensive system-level interventions to 
address health disparities in ASD (Zuckerman, Lindly, Sinche, & Nicolaidis, 2015). When 
clinical interventions are informed by an awareness of family beliefs, families are more 
engaged in the intervention process (King et al., 2006). The findings of this study will help 
researchers, clinicians and other health professionals utilize information about parents’ 
beliefs regarding causal factors related to their child’s autism in discussions about treatment 
interventions to parents of children with ASD.
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Key points
• Few studies have examined the choice of treatments sought by parents of 
children with ASD and what influences those choices.
• Findings from this study suggest beliefs about etiology of ASD may influence 
the types, consistency and intensity of services and treatments sought.
• Healthcare providers need to encourage and facilitate open discussions with 
families about current knowledge regarding etiologies, the relationship (or 
lack thereof) of etiology to evidence based treatments, and the importance of 
ongoing communication regarding decisions about complementary or 
alternative treatment choices that require monitoring for safety and efficacy.
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